Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Lucidarme

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, EnglandShamez N Ladhani, Helen Campbell, Nick Andrews, et al.
Travel Medicine and Infectious Disease|May 13, 2023
Carriage of Neisseria meningitidis among travelers attending the Hajj pilgrimage, circulating serogroups, sequence types and antimicrobial susceptibility: A multinational longitudinal cohort studySaber Yezli, Yara Yassin, Abdulaziz Mushi, et al.
The Journal of Infection|March 31, 2016
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distributionStephen A Clark, Aiswarya Lekshmi, Jay Lucidarme, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2025
Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025Helen Campbell, Jay Lucidarme, Stephen A Clark, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023Kirsty Foster, Emma J Heymer, Helen Campbell, et al.
Clinical and Vaccine Immunology : CVI|June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamicaJay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
The Journal of Infectious Diseases|May 24, 2019
Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 LineageLuke R Green, Neelam Dave, Adeolu B Adewoye, et al.
The Journal of Infection|September 9, 2023
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in EnglandStephen A Clark, Helen Campbell, Sonia Ribeiro, et al.
Plos One|May 31, 2018
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccinesCaroline Cayrou, Ayodeji A Akinduko, Evgeny M Mirkes, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, EnglandShamez N Ladhani, Helen Campbell, Nick Andrews, et al.
Travel Medicine and Infectious Disease|May 13, 2023
Carriage of Neisseria meningitidis among travelers attending the Hajj pilgrimage, circulating serogroups, sequence types and antimicrobial susceptibility: A multinational longitudinal cohort studySaber Yezli, Yara Yassin, Abdulaziz Mushi, et al.
The Journal of Infection|March 31, 2016
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distributionStephen A Clark, Aiswarya Lekshmi, Jay Lucidarme, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2025
Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025Helen Campbell, Jay Lucidarme, Stephen A Clark, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023Kirsty Foster, Emma J Heymer, Helen Campbell, et al.
Clinical and Vaccine Immunology : CVI|June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamicaJay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
The Journal of Infectious Diseases|May 24, 2019
Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 LineageLuke R Green, Neelam Dave, Adeolu B Adewoye, et al.
The Journal of Infection|September 9, 2023
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in EnglandStephen A Clark, Helen Campbell, Sonia Ribeiro, et al.
Plos One|May 31, 2018
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccinesCaroline Cayrou, Ayodeji A Akinduko, Evgeny M Mirkes, et al.
Pageof 9